Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data

BMC Health Services Research

Volumn 11, Issue , 2011, Pages

  Mapel, Douglas W ^a   Dutro, Michael P ^b   Marton, Jen P ^b   Woodruff, Kimberly ^b   Make, Barry ^c  

^a LOVELACE CLINIC FOUNDATION   (United States)

^b PFIZER INC   (United States)

^c DEPARTMENT OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROSS-SECTIONAL STUDY; FEMALE; HEALTH INSURANCE; HUMAN; INSURANCE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; STATISTICS; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 79951851181     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-11-43     Document Type: Article

References (24)

1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. (Updated 2009). Global Initiative for Chronic Obstructive Lung Disease (GOLD), http://www.goldcopd.org/ Accessed January 13, 2011
2. -2009 Chartbook on Cardiovascular, Lung, and Blood Diseases. National Heart Lung and Blood Institute. Morbidity and Mortality, http://www.nhlbi.nih. gov/resources/docs/2009-ChartBook.pdf Accessed January 13, 2011
3. COPD predicted to be third leading cause of death in 2030. World Health Organization, http://www.who.int/respiratory/copd/World-Health-Statistics-2008/ en/print.html Accessed January 13, 2011
4. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. DP Tashkin B Celli S Senn D Burkhart S Kesten S Menjoge M Decramer, N Engl J Med 2008 359 1543 1554 10.1056/NEJMoa0805800 18836213
5. Bronchodilator responsiveness in patients with COPD. DP Tashkin B Celli M Decramer D Liu D Burkhart C Cassino S Kesten, Eur Respir J 2008 31 742 750 10.1183/09031936.00129607 18256071
6. Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline. TJ Wilt D Niewoehner R MacDonald RL Kane, Ann Intern Med 2007 147 639 653 17975187 (Pubitemid 351664485)
7. Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization. DW Mapel JS Hurley FJ Frost HV Petersen MA Picchi DB Coultas, Arch Intern Med 2000 160 2653 2658 10.1001/archinte.160.17.2653 10999980
8. Patterns of hospitalization in elderly patients with asthma and chronic obstructive pulmonary disease. K Cydulka Rita ER McFadden Jr L Emerman Charles D Sivinski Lynn W Pisanelli A Rimm Alfred, Am J Respir Crit Care Med 1997 156 1807 1812 9412559 (Pubitemid 28011786)
9. Prevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general population. C Anecchino E Rossi C Fanizza M De Rosa G Tognoni M Romero, Int J Chron Obstruct Pulmon Dis 2007 2 567 574 18268930
10. Mortality in COPD: Role of comorbidities. DD Sin NR Anthonisen JB Soriano AG Agusti, Eur Respir J 2006 28 1245 1257 10.1183/09031936.00133805 17138679 (Pubitemid 44883863)
11. Mortality by cause for eight regions of the world: Global Burden of Disease Study. CJ Murray AD Lopez, Lancet 1997 349 1269 1276 10.1016/S0140-6736(96)07493-4 9142060 (Pubitemid 27192468)
12. Standards for the Diagnosis and Management of Patients with COPD [Internet]. American Thoracic Society/European Respiratory Society Task Force, New York: American Thoracic Society, Version 1.2 http://www.thoracic.org/go/copd Accessed January 13, 2011
13. Comorbidities in chronic obstructive pulmonary disease. WM Chatila BM Thomashow OA Minai GJ Criner BJ Make, Proc Am Thorac Soc 2008 5 549 555 10.1513/pats.200709-148ET 18453370 (Pubitemid 351669185)
14. Predictors of rehospitalization and death after a severe exacerbation of COPD. R McGhan T Radcliff R Fish ER Sutherland C Welsh B Make, Chest 2007 132 1748 1755 10.1378/chest.06-3018 17890477
15. Comorbidity, hospitalization, and mortality in COPD: Results from a longitudinal study. C Terzano V Conti F Di Stefano A Petroianni D Ceccarelli E Graziani S Mariotta A Ricci A Vitarelli G Puglisi C De Vito P Villari L Allegra, Lung 2010 188 321 329 10.1007/s00408-009-9222-y 20066539
16. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. PM Calverley JA Anderson B Celli GT Ferguson C Jenkins PW Jones JC Yates J Vestbo, N Engl J Med 2007 356 775 789 10.1056/NEJMoa063070 17314337 (Pubitemid 46294610)
17. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. DM Mannino DE Doherty A Sonia Buist, Respir Med 2006 100 115 122 10.1016/j.rmed.2005.03.035 15893923 (Pubitemid 43039873)
18. Mortality after an emergency department visit for exacerbation of chronic obstructive pulmonary disease. S Kim S Clark CA Camargo Jr, COPD 2006 3 75 81 10.1080/15412550600651271 17175669 (Pubitemid 43739178)
19. Toward a consensus definition for COPD exacerbations. R Rodriguez-Roisin, Chest 2000 117 398S 401S 10.1378/chest.117.5-suppl-2.398S 10843984 (Pubitemid 30314474)
20. Lung function decline and outcomes in an elderly population. DM Mannino KJ Davis, Thorax 2006 61 472 477 10.1136/thx.2005.052449 16517577 (Pubitemid 43901515)
21. Risk factors for accelerated decline among patients with chronic obstructive pulmonary disease. HA Kerstjens PL Brand DS Postma, Am J Respir Crit Care Med 1996 154 266 272 8970399
22. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review. EL Toy KF Gallagher EL Stanley AR Swensen MS Duh, COPD 2010 7 214 228 10.3109/15412555.2010.481697 20486821
23. The costs of exacerbations in chronic obstructive pulmonary disease (COPD). F Andersson S Borg SA Jansson AC Jonsson A Ericsson C Prutz E Ronmark B Lundback, Respir Med 2002 96 700 708 10.1053/rmed.2002.1334 12243316
24. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. JB Soriano KJ Davis B Coleman G Visick D Mannino NB Pride, Chest 2003 124 474 481 10.1378/chest.124.2.474 12907531 (Pubitemid 37000122)